Ingredient
P-Chloro-M-Cresol
P-Chloro-M-Cresol is flagged for pregnancy, breastfeeding, trying to conceive and PCOS. The concern behind the strongest flag is endocrine disruptor and absorbed into the body.
- PCMC
- 4-Chloro-3-Methylphenol
- Chlorocresol
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 4 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 3 of 5
- Higher means more likely to sting or redden
P-Chloro-M-Cresol and pregnancy
Caution Advised
- Endocrine disruptor
- Absorbed into the body
P-Chloro-M-Cresol is a preservative that prevents bacterial and fungal growth in cosmetic products. It belongs to the phenolic compound class and has antimicrobial properties that extend product shelf life. The primary concern during pregnancy is PCMC's potential weak estrogenic activity, which raises questions about endocrine disruption during fetal development. While studies on topical use in pregnant women are limited, research suggests PCMC can be absorbed through skin and has been detected in urine samples. The ingredient's ability to potentially interfere with hormonal signaling is particularly concerning during pregnancy when hormonal balance is critical for fetal development. Additionally, PCMC is a known allergen, and pregnancy can increase skin sensitivity. The SCCS has expressed concerns about PCMC's endocrine-disrupting potential and allergenic properties, though it remains approved at low concentrations in EU cosmetics. No major obstetric organizations have issued specific guidance on PCMC, but the precautionary principle suggests limiting exposure to potential endocrine disruptors during pregnancy. Many dermatologists recommend pregnant women choose preservative systems without phenolic compounds when possible, particularly for leave-on products used over large body areas.
P-Chloro-M-Cresol and breastfeeding
Caution Advised
- Endocrine disruptor
- Infant exposure
P-Chloro-M-Cresol can be absorbed through skin and potentially enter the bloodstream. While specific data on transfer to breast milk is limited, the ingredient's lipophilic properties and systemic absorption raise theoretical concerns. The weak estrogenic activity of PCMC is a concern during breastfeeding, as hormones and hormone-like compounds can pass into breast milk and potentially affect infant development. Additionally, if products containing PCMC are applied to or near breast tissue, there's increased risk of direct infant exposure through skin contact during breastfeeding. The ingredient's allergenic potential also means that sensitized mothers may experience contact dermatitis. While there are no absolute prohibitions on PCMC use during breastfeeding, conservative dermatologists often recommend avoiding products with potential endocrine-disrupting preservatives when safer alternatives exist. The European Commission's ongoing evaluation of endocrine disruptors in cosmetics has flagged PCMC for further assessment, suggesting caution is warranted.
P-Chloro-M-Cresol and postpartum
Safe to Use
- Common allergen
- Irritant
For postpartum women who are not breastfeeding, PCMC presents primarily dermatological concerns rather than systemic ones. Postpartum skin can be more sensitive due to hormonal changes, making allergic reactions or irritation more likely. The ingredient's known allergenic potential means patch testing or gradual introduction of products may be advisable for those with sensitive skin. However, without the concern of infant exposure through breastfeeding, PCMC-containing products pose minimal health risk when used at regulated concentrations in cosmetics.
P-Chloro-M-Cresol and trying to conceive
Caution Advised
- Endocrine disruptor
- Hormone disruptor
Women trying to conceive are working to optimize hormonal balance for ovulation and implantation. P-Chloro-M-Cresol's weak estrogenic activity raises theoretical concerns about interference with natural hormonal cycling, though direct evidence linking topical PCMC to fertility issues is lacking. The precautionary principle suggests minimizing exposure to potential endocrine disruptors when trying to conceive. While the risk from cosmetic use is likely low due to limited systemic absorption, choosing products with alternative preservatives eliminates this theoretical concern entirely. Many fertility specialists recommend reducing exposure to chemicals with known or suspected hormonal activity during the preconception period.
P-Chloro-M-Cresol and PCOS
Caution Advised
- Endocrine disruptor
- Interferes with hormones
P-Chloro-M-Cresol has demonstrated weak estrogenic activity in laboratory studies, meaning it can potentially interact with estrogen receptors in the body. For women with PCOS, who already experience hormonal imbalance, additional endocrine-disrupting exposures are concerning. PCOS involves complex hormonal dysregulation affecting estrogen, androgens, and insulin. While PCMC's estrogenic effects are considered weak, repeated daily exposure through cosmetic products could theoretically contribute to hormonal disruption. Research specifically linking PCMC to PCOS symptom exacerbation doesn't exist, but the precautionary approach suggests minimizing exposure to potential endocrine disruptors. Women managing PCOS through hormonal balance may wish to choose cosmetics with alternative preservatives that lack endocrine-disrupting potential. The ingredient is particularly worth avoiding if using hormone-based PCOS treatments, though topical PCMC exposure is much lower than from pharmaceutical routes.
P-Chloro-M-Cresol and general use
Safe to Use
- Common allergen
- Irritant
For the general population, P-Chloro-M-Cresol functions effectively as a preservative at low concentrations. The primary concern is contact allergy, which affects a subset of sensitized individuals. Studies show PCMC has a sensitization rate of approximately 1-3% in tested populations. The ingredient can cause irritation, particularly in products applied to sensitive areas or used at higher concentrations. People with eczema, sensitive skin, or known fragrance/preservative allergies may be more susceptible to reactions. Symptoms typically include redness, itching, or contact dermatitis at application sites. The SCCS has evaluated PCMC multiple times and, while expressing concerns about allergenic potential and possible endocrine effects, considers it safe at restricted concentrations in cosmetics. The EU limits PCMC to 0.2% in most products. Individuals with known PCMC sensitivity should avoid products listing it on ingredient labels.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of P-Chloro-M-Cresol, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store